Cargando…

The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis

(1) Background: The coronavirus 2019 pandemic has resulted in an abrupt transition to virtual oncology care worldwide. This study’s objective is to evaluate chemotherapy delivery and clinical outcomes in patients on systemic treatment for colorectal cancer before and during the pandemic. (2) Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, William J., Leung, Macyn, Thavorn, Kednapa, Asmis, Timothy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497499/
https://www.ncbi.nlm.nih.gov/pubmed/36135058
http://dx.doi.org/10.3390/curroncol29090489
_version_ 1784794520517345280
author Phillips, William J.
Leung, Macyn
Thavorn, Kednapa
Asmis, Timothy R.
author_facet Phillips, William J.
Leung, Macyn
Thavorn, Kednapa
Asmis, Timothy R.
author_sort Phillips, William J.
collection PubMed
description (1) Background: The coronavirus 2019 pandemic has resulted in an abrupt transition to virtual oncology care worldwide. This study’s objective is to evaluate chemotherapy delivery and clinical outcomes in patients on systemic treatment for colorectal cancer before and during the pandemic. (2) Methods: Clinical data was collected on patients with colorectal cancer receiving intravenous chemotherapy at The Ottawa Hospital from June 2019 to March 2021. Patients were stratified by whether they were started on chemotherapy pre-pandemic (June 2019–January 2020) or intra-pandemic (February 2020–March 2021). Multiple regression analysis was used to compare outcomes between pandemic periods; (3) Results: There were 220 patients included in this study. The proportion of virtual consultations (1.2% to 64.4%) and follow-up visits (5.2% to 83.3%) increased during the pandemic. There was no difference in the incidence of treatment delays (OR = 1.01, p = 0.78), chemotherapy dose reductions (OR = 0.99, p = 0.69), emergency department visits (OR = 1.23, p = 0.37) or hospitalizations (OR = 0.73, p = 0.43) between pandemic periods. A subgroup analysis revealed no difference in outcomes independent of the presence of metastases; (4) Conclusion: These findings serve as an important quality-care indicator and demonstrate that virtual oncology care appears safe in a cohort of high-risk colorectal cancer patients.
format Online
Article
Text
id pubmed-9497499
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94974992022-09-23 The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis Phillips, William J. Leung, Macyn Thavorn, Kednapa Asmis, Timothy R. Curr Oncol Article (1) Background: The coronavirus 2019 pandemic has resulted in an abrupt transition to virtual oncology care worldwide. This study’s objective is to evaluate chemotherapy delivery and clinical outcomes in patients on systemic treatment for colorectal cancer before and during the pandemic. (2) Methods: Clinical data was collected on patients with colorectal cancer receiving intravenous chemotherapy at The Ottawa Hospital from June 2019 to March 2021. Patients were stratified by whether they were started on chemotherapy pre-pandemic (June 2019–January 2020) or intra-pandemic (February 2020–March 2021). Multiple regression analysis was used to compare outcomes between pandemic periods; (3) Results: There were 220 patients included in this study. The proportion of virtual consultations (1.2% to 64.4%) and follow-up visits (5.2% to 83.3%) increased during the pandemic. There was no difference in the incidence of treatment delays (OR = 1.01, p = 0.78), chemotherapy dose reductions (OR = 0.99, p = 0.69), emergency department visits (OR = 1.23, p = 0.37) or hospitalizations (OR = 0.73, p = 0.43) between pandemic periods. A subgroup analysis revealed no difference in outcomes independent of the presence of metastases; (4) Conclusion: These findings serve as an important quality-care indicator and demonstrate that virtual oncology care appears safe in a cohort of high-risk colorectal cancer patients. MDPI 2022-08-29 /pmc/articles/PMC9497499/ /pubmed/36135058 http://dx.doi.org/10.3390/curroncol29090489 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Phillips, William J.
Leung, Macyn
Thavorn, Kednapa
Asmis, Timothy R.
The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title_full The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title_fullStr The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title_full_unstemmed The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title_short The Impact of Virtual Cancer Care on Chemotherapy Delivery and Clinical Outcomes in Colorectal Cancer Patients Receiving Systemic Therapy: A Pre- and Intra-Pandemic Analysis
title_sort impact of virtual cancer care on chemotherapy delivery and clinical outcomes in colorectal cancer patients receiving systemic therapy: a pre- and intra-pandemic analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497499/
https://www.ncbi.nlm.nih.gov/pubmed/36135058
http://dx.doi.org/10.3390/curroncol29090489
work_keys_str_mv AT phillipswilliamj theimpactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT leungmacyn theimpactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT thavornkednapa theimpactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT asmistimothyr theimpactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT phillipswilliamj impactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT leungmacyn impactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT thavornkednapa impactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis
AT asmistimothyr impactofvirtualcancercareonchemotherapydeliveryandclinicaloutcomesincolorectalcancerpatientsreceivingsystemictherapyapreandintrapandemicanalysis